Mankind up 7% ahead of board meet for fund raising; m-cap tops Rs 1 trn

Q: How long will it take to read this news story?

The story "Mankind up 7% ahead of board meet for fund raising; m-cap tops Rs 1 trn" has 748 words across 27 sentences, which will take approximately 4 - 7 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Mankind up 7% ahead of board meet for fund raising; m-cap tops Rs 1 trn" was covered 1 weeks ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 298 news stories per day. It's most recent story was published 5 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #22616310</li><li>URL: https://beamstart.com/news/mankind-up-7-ahead-of-17268101242089</li></ul>

Business Standard Logo Business Standard 1w ago

Mankind up 7% ahead of board meet for fund raising; m-cap tops Rs 1 trn - Business Standard

Quick Summary:

The board is to consider and approve the raising of funds by way of issue of non-convertible debentures, commercial papers, other debt securities or any other security or any combination thereof.

Currently, Mankind Pharma is trading 140 per cent higher over its issue price of Rs 1,080 per share.

Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic segments as well as several consumer healthcare products.